| Literature DB >> 32008742 |
Asami Watahiki1, Kouhei Shimizu2, Seira Hoshikawa3, Mitsuki Chiba1, Hiroshi Kitamura4, Hiroshi Egusa1, Satoshi Fukumoto5, Hiroyuki Inuzuka6.
Abstract
Lipin-2 is a phosphatidate phosphatase with key roles in regulating lipid storage and energy homeostasis. LPIN2-genetic deficiency is associated with an autoinflammatory disorder, underscoring its critical role in innate immune signaling; however, the regulatory mechanisms underlying protein stability remain unknown. Here, we demonstrate that Lipin-2 interacts with β-TRCP, a substrate receptor subunit of the SCFβ-TRCP E3 ligase, and undergoes ubiquitination and proteasomal degradation. β-TRCP-knockout in RAW264.7 macrophages resulted in Lipin-2 accumulation, leading to the suppression of LPS-induced MAPK activation and subsequent proinflammatory gene expression. Consistent with this, treatment with MLN4924, a Cullin-neddylation inhibitor that suppresses SCF E3 activity, increased Lipin-2 protein and concomitantly decreased Il1b expression. These findings suggested that β-TRCP-mediated Lipin-2 degradation affects macrophage-elicited proinflammatory responses and could lead to new therapeutic approaches to treat inflammatory diseases.Entities:
Keywords: IL-1β; Inflammation; Lipin-2; MLN4924; Ubiquitination; β-TRCP
Mesh:
Substances:
Year: 2020 PMID: 32008742 DOI: 10.1016/j.bbrc.2020.01.119
Source DB: PubMed Journal: Biochem Biophys Res Commun ISSN: 0006-291X Impact factor: 3.575